PDK4 and urinary bladder carcinoma: Upregulation of PDK4 is observed in high-grade invasive bladder cancers compared with low-grade bladder cancers, and Knockdown or inactivation of PDK4 delays cell proliferation and sensitizes bladder cancer cells to cisplatin (Woolbright et al., 2018).